The directives are considered as a move initiated by the industry to foster correct and standardized studies with stem cells, also in view of patent applications.

China Bio news, October 14, 2013

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny